Clinical Trials on Influenza-like Illness in Finland

Total 221 results

Novartis Vaccines

Completed

Immunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 Years

Prophylaxis of Avian Influenza

Finland
Finnish Institute for Health and Welfare

Completed

Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11

Influenza Caused by the 2009 H1N1 Influenza Virus

Finland
Finnish Institute for Health and Welfare

Completed

Evaluation of Pandemic Vaccination Campaign

Influenza Caused by the Novel A(H1N1)v Influenza Virus

Finland
Sanofi Pasteur, a Sanofi Company

Terminated

Study to Evaluate the Effectiveness of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Adults 65 Years of Age and Older

Influenza (Healthy Volunteers)

Finland
Ology Bioservices

Completed

Immunogenicity and Safety Study of a Single Prime-Boost Vaccination Schedule With a H5N1 Influenza Vaccine in Adults

Influenza | Avian Influenza

Austria, Finland
Novartis
Novartis Vaccines

Completed

Safety, Tolerability and Immunogenicity of Two Doses of Adjuvanted Monovalent Influenza Vaccine Administered to Healthy Adult and Elderly Subjects

Pandemic Influenza Disease

Finland, Germany
Sanofi

Completed

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2023/24

Influenza Immunization (Healthy Volunteers)

Finland, Germany
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of FluarixTM Vaccine in Children Who Have Previously Been Vaccinated With PandemrixTM

Influenza

Finland
Novartis Vaccines

Completed

Safety and Immunogenicity of 2 Commercially Available Influenza Vaccines in Children

Influenza

Finland
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold- Adapted (CAIV-T) in Healthy Children Attending Day Care Centers

Influenza

Finland
MedImmune LLC

Completed

Trial of the Safety, Transmissibility, and Phenotypic and Genotypic Stability of Influenza Virus Vaccine,(CAIV-T), in Children Who Attend Day Care. (Final Report Version 2.0)

Influenza

Finland
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months

Influenza

Finland
Finnish Institute for Health and Welfare
Hospital District of Helsinki and Uusimaa

Recruiting

Immune Responses in Health Care Personnel

Influenza

Finland
Finnish Institute for Health and Welfare
RWTH Aachen University; University of Erfurt

Completed

Herd Immunity and Influenza Vaccine Uptake (HIIVU)

Influenza, Human

Finland
Novartis Vaccines

Completed

Immunogenicity and Safety Following a Single Dose of Influenza Vaccines in Healthy Children Who Received Either One or the Other Vaccine (an Adjuvanted Sub-unit Influenza Vaccine and a Non-adjuvanted Split Virion Influenza Vaccine) in the Previous V70P2 Study

FLU

Finland
Turku University Hospital
University of Turku; University of Helsinki

Completed

Clinical Trial on Individual Characteristics Affecting Pain Drug Therapy in Neonates (NeoPopGen)

Critical Illness

Finland
Helsinki University Central Hospital

Completed

Responsiveness Index Versus the RASS Based Method for Adjusting Sedation in Critically Ill Patients

Critical Illness

Finland
Hospital District of Southwestern Finland
Hoffmann-La Roche

Completed

Early Oseltamivir Treatment of Influenza in Children 1-3 Years of Age (ETOPOM)

Influenza

Finland
Helsinki University Central Hospital
FinnHEMS Oy

Completed

POC Analysis of IO Blood Samples Within Critically Ill Patients

Critically Ill

Finland
Helsinki University Central Hospital
Oulu University Hospital; FinnHEMS

Completed

Brain Oxygenation During Prehospital Anesthesia (BOPRA-P)

Critical Illness

Finland
Finnish Institute for Health and Welfare
University of Helsinki; European Commission; Ministry of Internal Affairs, Finland

Completed

Whole Blood-plasma-oral Fluid Ratios of Psychoactive Drugs and Medicines

Driving Under the Influence

Finland
Finnish Institute for Health and Welfare
European Commission; Ministry of Internal Affairs, Finland

Completed

Testing Alcohol Only Samples for Drugs and Drugs Only Samples for Alcohol

Driving Under the Influence

Finland
Helsinki University Central Hospital
University of Copenhagen

Completed

Use of suPAR Algorithm for the ED Decision Making (EDsuPAR)

Critical Illness

Finland
Sanofi Pasteur, a Sanofi Company

Completed

Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants

Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type b

Finland, Sweden
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine

Neisseria Meningitidis | Haemophilus Influenzae Type b

United States, Australia, Mexico
Ology Bioservices

Completed

Safety and Immunogenicity Study of a H5N1 Influenza Vaccine (Vero Cell-Derived, Whole Virus) in Healthy Infants, Children and Adolescents

Influenza, Avian

Australia, Finland, Singapore, Spain
Finnish Institute of Occupational Health
City of Helsinki; Finnish Work Environment Fund; The Social Insurance Institution... and other collaborators

Completed

Comparing Interventions for Indoor Air -Related Functional Symptoms (TOSI)

Environmental Illness | Functional Symptoms

Finland
VA Office of Research and Development

Not yet recruiting

Home-based Exercise for SMI

Serious Mental Illness

United States
Sanofi Pasteur, a Sanofi Company

Completed

A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 Months

Influenza | Swine-origin A/H1N1 Influenza

Finland
Sanofi Pasteur, a Sanofi Company

Completed

A Study of Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years

Influenza | Swine-origin A/H1N1 Influenza

Finland
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Children

Influenza | Orthomyxoviridae Infections | Orthomyxovirus Infections

Finland
Sanofi Pasteur, a Sanofi Company

Completed

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2021/22

Influenza (Healthy Volunteers)

Germany, Finland
Sanofi Pasteur, a Sanofi Company

Completed

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2022/23

Influenza (Healthy Volunteers)

Germany, Finland
Turku University Hospital
Turku University of Applied Sciences

Completed

Implementation of Pit Crew Resuscitation Model on the Training of Advanced Life Support: a Randomized Controlled Study

Advanced Cardiac Life Support

Finland
University of California, San Francisco
Kenya Medical Research Institute; Organic Health Response; Microclinic International

Completed

Healthy Networks Water Treatment Study (HNWT)

Household Water Treatment | Waterborne Illness

Kenya
Helsinki University Central Hospital
University Hospital Inselspital, Berne

Completed

Targeted Tissue Perfusion Versus Macrocirculatory-guided Standard Care in Patients With Septic Shock (TARTARE-2S)

Critical Illness | Shock; Septic

Finland, Switzerland
University of Helsinki

Completed

Let´s Talk About Children Intervention in a School Context

Burnout | Children's Wellbeing | Child Overall Health Related Quality of Life

Finland
GlaxoSmithKline

Completed

A Study to Demonstrate the Efficacy of GSK Biologicals' Influenza Vaccine in Adults

Influenza

Finland, Czech Republic
Helsinki University Central Hospital
City of Helsinki

Completed

Intrauterine Contraception After First Trimester Abortion - Effects on Quality of Life and Risk of Repeat Abortion.

Contraception

Finland
Helsinki University Central Hospital
Turku University Hospital; Oulu University Hospital; Kuopio University Hospital; Tampere University and other collaborators

Active, not recruiting

Brain Oxygenation During Prehospital Anesthesia: an Observational Study (BOPRA)

Emergencies | Anesthesia | Critically Ill | Major Trauma

Finland
Turku University Hospital

Unknown

The Quality of Life in Late Menopause (QoL)

Quality of Life

Finland
Society for Gynecological Surgery in Finland

Active, not recruiting

FINPOP 2015: Incidence, Methods, Complications and Quality of Life of Pelvic Organ Prolapse Operations in Finland 2015

Pelvic Organ Prolapse

Finland
GlaxoSmithKline

Completed

Study to Evaluate an Influenza Vaccine Candidate

Influenza

Finland, Greece
Novartis Vaccines

Completed

Immunogenicity and Safety of V70P5 Revaccination Subjects

Influenza

Finland
University of Eastern Finland
Kuopio University Hospital; Savonia University of Applied Sciences; Kuopio Conservatory

Unknown

JOYof ART - an Intervention Study (JOYofART)

Quality of Life | Family Caregivers

Finland
Insight Therapeutics, LLC
Brown University

Completed

High Dose Influenza Vaccine in Nursing Home - Pilot Study

Influenza

United States
Ology Bioservices

Completed

Phase 1 Study of a H5N1 Influenza Vaccine (Reverse Genetic Reassortant)

Influenza | Pandemic Influenza

United States
GlaxoSmithKline

Completed

Primary & Booster Study in Infants to Demonstrate Non-inferiority, Persistence & Immunogenicity of Hib-MenC Vaccine

Neisseria Meningitidis | Haemophilus Influenzae Type b

Finland, Italy
Helsinki University Central Hospital

Completed

Traumatic Below-knee Amputees With Prosthetics: Health-related Quality of Life and Locomotor Capabilities

Amputees

Finland
Helsinki University Central Hospital
The Swedish Research Council

Completed

Heparin Binding Protein in Patients With Acute Respiratory Failure Treated With GCSF (Filgrastim) (HBP-Neupogen)

Critically Ill | Acute Respiratory Failure

Finland

Clinical Trials on Influenza-like Illness in Finland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations